Swiss National Bank - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$27,047,601
+0.2%
170,100
-10.9%
0.02%
+16.7%
Q2 2023$27,004,714
-23.2%
190,900
-8.6%
0.02%
-25.0%
Q1 2023$35,170,404
-3.0%
208,900
-2.4%
0.02%
-7.7%
Q4 2022$36,249,271
+55.1%
214,100
+71.4%
0.03%
+52.9%
Q3 2022$23,370,000
+16.1%
124,900
+0.8%
0.02%
+21.4%
Q2 2022$20,121,000
-13.9%
123,900
-0.2%
0.01%
+7.7%
Q1 2022$23,361,000
-23.3%
124,200
+8.0%
0.01%
-27.8%
Q4 2021$30,457,000
-8.5%
115,000
-0.2%
0.02%
-14.3%
Q3 2021$33,292,000
+45.4%
115,200
+0.4%
0.02%
+50.0%
Q2 2021$22,896,000
+3.0%
114,700
+0.3%
0.01%
-6.7%
Q1 2021$22,221,000
+2.8%
114,300
+1.3%
0.02%0.0%
Q4 2020$21,616,000
+30.1%
112,800
+0.2%
0.02%
+15.4%
Q3 2020$16,613,000
+21.6%
112,600
+1.9%
0.01%
+8.3%
Q2 2020$13,659,000
+55.7%
110,500
+21.6%
0.01%
+33.3%
Q1 2020$8,775,000
+6.9%
90,900
+2.5%
0.01%
+12.5%
Q4 2019$8,205,000
+31.4%
88,700
+9.0%
0.01%
+14.3%
Q3 2019$6,243,000
-1.2%
81,400
+10.7%
0.01%0.0%
Q2 2019$6,317,000
+57.5%
73,500
+8.2%
0.01%
+75.0%
Q1 2019$4,012,000
+15.6%
67,900
+3.2%
0.00%0.0%
Q4 2018$3,470,000
-3.6%
65,800
+1.4%
0.00%0.0%
Q3 2018$3,599,000
+17.9%
64,9000.0%0.00%
+33.3%
Q2 2018$3,053,000
+30.0%
64,9000.0%0.00%0.0%
Q1 2018$2,348,000
+1.6%
64,900
+1.9%
0.00%
+50.0%
Q4 2017$2,311,000
-0.3%
63,700
+5.3%
0.00%
-33.3%
Q3 2017$2,318,000
-7.5%
60,5000.0%0.00%0.0%
Q2 2017$2,507,000
+28.3%
60,500
+9.0%
0.00%
+50.0%
Q1 2017$1,954,000
+14.2%
55,5000.0%0.00%
-33.3%
Q4 2016$1,711,000
+2.1%
55,5000.0%0.00%0.0%
Q3 2016$1,676,000
+8.1%
55,500
-2.1%
0.00%0.0%
Q2 2016$1,551,000
+12.4%
56,700
+6.6%
0.00%0.0%
Q1 2016$1,380,000
+11.4%
53,200
+21.5%
0.00%0.0%
Q4 2015$1,239,000
+1.6%
43,8000.0%0.00%0.0%
Q3 2015$1,220,000
-13.0%
43,800
+28.8%
0.00%
-25.0%
Q2 2015$1,403,000
+40.0%
34,000
+3.0%
0.00%
+33.3%
Q1 2015$1,002,000
+53.4%
33,0000.0%0.00%
+50.0%
Q4 2014$653,000
+1.6%
33,000
+2.2%
0.00%0.0%
Q3 2014$643,000
-12.6%
32,3000.0%0.00%
-33.3%
Q2 2014$736,00032,3000.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders